乳腺癌的临床试验终点事件的时间定义指南 —_2015
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
1
© The Author 2015. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@. Guidelines for time-to-event endpoint definitions in Breast cancer trials: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
S. Gourgou-Bourgade 1,*, D. Cameron², P. Poortmans 3, B. Asselain 4, D. Azria 5, F. Cardoso 6, R. A’Hern Roger 7, J. Bliss Judith 7, J. Bogaerts Jan 8, H. Bonnefoi Hervé9, E. Brain Etienne 10, M.J. Cardoso 6, B. Chibaudel 11, R. Coleman 12, T. Cufer 13, L. Dal Lago 14, F. Dalenc 15, E. De Azambuja 14, M. Debled 9, S. Delaloge 16, T. Filleron 15, J. Gligorov 17, M. Gutowski 18, W. Jacot 19, C. Kirkove 20, G. MacGrogan 9, S. Michiels 21,22, I. Negreiros Ida 23, B.V. Offersen 24, F. Penault Llorca 25,26, G. Pruneri 27,28, H. Roche 15, N.S. Russell 29, F. Schmitt 30,31, V. Servent 32, B. Thürlimann 33, M. Untch 34, J.A. van der Hage 35, G. van Tienhoven 36, H. Wildiers 37, J. Yarnold 38, F. Bonnetain 39, S. Mathoulin-Pélissier 40,41, C. Bellera 40,41, T.S. Dabakuyo-Yonli 42 1Biostatistic Unit, Montpellier Cancer Institute, Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France
2Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom
3Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands
4Institut Curie, Paris France
5Department of radiation oncology, Montpellier Cancer Institute, Montpellier, France
6Breast Cancer Unit, Champalimaud Cancer Center Lisbon, Portugal
7Institute of Cancer Research, London, United Kingdom
8EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics department), Brussels Belgium
9Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France
10Departments of Clinical Research & Medical Oncology, Institut Curie - Hôpital René Huguenin Saint-Cloud, France
11Department of Medical Oncology - Hôpital Saint-Antoine - Paris, France
12FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre Sheffield, United Kingdom
Annals of Oncology Advance Access published February 27, 2015 by guest on March 2, 2015
/Downloaded from
13University Clinic Golnik, Slovenia
14Institut Jules Bordet, University « Libre » of Brussels, Brussels, Belgium
15Institut Claudius Régaud Toulouse, France
16Breast Cancer Group, Gustave Roussy Institute, Villejuif, France
17APHP Tenon – University Cancer Institute – Pierre & Marie Curie, Sorbonne University, Paris, France
18Department of surgery, Montpellier Cancer Institute, Montpellier, France
19Department of medical oncology, Montpellier Cancer Institute, Montpellier, France
20Université catholique Louvain, Belgium
21Gustave Roussy, Biostatistic and Epidemiology Unit, Villejuif, France
22University of Paris-Sud, Villejuif, France
23Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal
24Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
25Centre Jean Perrin, Clermont-Ferrand, France
26University of Clermont-Ferrand 1, ERTICA EA4677, UFR medicine, Clermont-Ferrand, France
27European Institute of Oncology, Milan, Italy
28University of Milan, School of Medicine, Milan, Italy
29Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands
30IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto , Portugal
31Medical Faculty of Porto University, Porto, Portugal
32Oscar Lambret Comprehensive Cancer Center, Lille, France
33Kantonsspital St.Gallen, Breast Center ; St.Gallen, Switzerland
34Clinic for Gynecology, Gynecologic Oncology and Obstetrics- Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany
35Department of Surgical Oncology, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital Amsterdam, The Netherlands by guest on March 2, 2015 / Downloaded from